|
|
Received: 04 November 2014
|
|
|
|
|
[1] |
Kapoor K, Banks P A. Acute pancreatitis in a patient treated with liraglutide[J]. JOP,2013, 14(2): 109-111.
|
[2] |
骞秀芳, 郭 喆, 胡常菊. 白藜芦醇对重症急性胰腺炎大鼠炎性细胞因子的影响 [J]. 武警医学,2013, 24(11): 948-950.
|
[3] |
Faserl K, Golderer G, Kremser L, et al. Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis[J]. J Clin Endocrinol Metab,2011, 96(1): 233-241.
|
[4] |
冀文丽, 王勤英. 检测维生素D 结合蛋白在重型肝炎中的意义[J]. 中国药物与临床,2008, 8(3): 246-247.
|
[5] |
陆 明, 杨 蓓, 蔡映云. 维生素D 结合蛋白基因多态性与吸烟所致慢性阻塞性肺疾病的关系[J]. 中华内科杂志,2004, 43(2): 117-120.
|
[6] |
Li W, Zhao X, Zou S, et al. Scanning assay of beta-galactosidase activity[J]. Prikl Biokhim Mikrobiol,2012, 48(6): 668-672.
|
[7] |
中华医学会外科学分会胰腺外科学组. 重症急性胰腺炎诊治指南[J]. 中华外科杂志,2007, 45(11): 727-729.
|
[8] |
Paul E, Bailey M, Van Lint A, et al. Performance of APACHE III over time in Australia and New Zealand: a retrospective cohort study[J]. Anaesth Intensive Care,2012, 40(6): 980-994.
|
[9] |
Alain V, Jeremy S W, Minoti V A. Molecular mechanisms of pancreatitis: Current opinion[J]. J Gastroenterol Hepatol,2008, 23(9): 1339-1348.
|
[10] |
Talukdar R, Vege S S. Recent developments in acute pancreatitis[J]. Clin Gastroenterol Hepatol,2009, 7(11): 3-9.
|
[11] |
Brtko J, Hartl A, Weiss R, et al. Retinoic acid receptor status in mouse spleen during a primary immune response against beta-galactosidase[J]. Endocr Regul, 2000, 34(3): 113-118.
|
[12] |
Brubaker J O, Thompson C M, Morrison L A, et al. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus[J]. J Immunol,1996, 157(4): 1598-1604.
|
[13] |
Saeki K, Kanai T, Nakano M, et al. CCL2-induced migration and SOCS3-mediated activation of macrophages are involved in cerulein-induced pancreatitis in mice[J]. Gastroenterology,2012, 142(4): 1010-1020.
|
[14] |
Kisker O, Onizuka S, Becker C M, et al. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice[J]. Neoplasia,2003, 5(1): 32-40.
|
|
|